Medical Advisory Board

  • Dr. Mark Clements, MD PhD
  • Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Children’s Mercy Hospitals, Kansas City, MO
  • Dr. Clements, MD PhD specializes in glucose variability, diabetes care technology and chronic complications in diabetes. Dr. Clements is an AAP fellow and received his medical degree and PhD in Developmental Neuroscience from the Washington University Medical School in St. Louis, MO. He completed his Pediatric Endocrinology fellowship at the University of Missouri at Kansas City. Dr. Clements brings a passion for data analytics and insights to his pediatric endocrinology practice at Children’s Mercy Hospitals and is known as a passionate innovator for the children he treats.

  • Dr. Jerome Fischer, MD
  • Diabetes and Glandular Disease Clinic (DGD), Clinial Instructor, University of Texas Health Science Center, San Antonio, TX
  • Dr. Fischer, MD is an accomplished researcher, partner and CIO of the Diabetes Glandular Disease (DGD) Clinic in San Antonio, TX. Dr. Fischer received his medical degree from the Thomas Jefferson Medical School in Philadelphia, Pennsylvania. He completed his fellowship in Endocrinology from the George Washington University Medical Center in Washington, DC. He has been involved as investigator in numerous research trials and is considered a leader in the most progressive use of diabetes education combined with technology and cutting-edge treatments to serve diabetes patients in Southern Texas.

  • Dr. Michael Greenfield, MD
  • Glooko Chief Medical Officer, Endocrinologist, El Camino Hospital, Palo Alto, CA
  • Dr. Michael Greenfield, MD is Glooko's Chief Medical Officer and diabetes technology expert. Dr. Greenfield received his medical degree from Harvard Medical School in Boston, MA and completed his Endocrinology fellowship at Stanford University in Palo Alto, CA. Dr. Greenfield helps to lead the Glooko effort to create patient and clinical relevant and innovative analytics. Dr. Greenfield chairs the Institutional Review Board (IRB) at El Camino Hospital in Silicon Valley and is an accomplished researcher and a beloved clinician.

  • Dr. David Kerr, MD
  • Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute, Santa Barbara, CA
  • Dr. David Kerr, MD is a UK trained physician and Endocrinologist, a former diabetes researcher at Yale and the former Editor of the Journal of Diabetes Science and Technology. Dr. Kerr received his medical degree in Internal Medicine and Endocrinology from the Aberdeen University in Scotland. After, he spent two years in the Division of Endocrinology at Yale University in the United States. Dr. Kerr is a Fellow of the Royal College of Physicians of Edinburgh, visiting Professor at Bournemouth University and has held a Gold Clinical Excellence Award from the National Health Service in the UK. He currently is the Director of Diabetes Research and Innovation at the Sansum Diabetes Research Institute in Santa Barbara, CA. You can follow him on twitter at @GoDiabetesMD.